Perioperative Research Into Memory: Cognitive Outcome Following Major Burns

Major Injury Clinical Trial

— PRiMe  

Official title:

Using Cognitive Tests and Functional MRI to Investigate Long Term Cognitive Dysfunction Following a Critical Illness Due to a Major Burn Injury

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03470844
• Other study ID #: C&W13/099
• Status: Completed
• First received: May 10, 2016
• Last updated: March 19, 2018
• Start date: August 5, 2015
• Est. completion date: October 30, 2017

Study information

• Verified date: March 2018
• Source: Chelsea and Westminster NHS Foundation Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The long term survival of patients who require admission to critical care (CC) following a major burn injury (MBI) continues to improve with advanced clinical management. There has been increasing interest into cognitive dysfunction (CD) due to neuroinflammation (NI) following CC, anaesthesia, surgery, and the association of NI with diseases characterised by CD such as Alzheimer's disease. Patients who suffer a MBI and who subsequently require admission to CC will be at uniquely high risk for CD. MBI produces an exaggerated and prolonged systemic inflammatory response, with NI demonstrated in animal models. Additionally NI can be exaggerated by insults such as sepsis, anaesthesia, and surgical trauma, common and often necessary following MBI. The aim of this study is to identify CD using cognitive tests to examine for deficits in working memory and executive function. Test proposed to use are the Hopkins Verbal Learning and Verbal Fluency tests, and a validated computerised battery (CogState). Neuroinflammation and underlying pathophysiology using fMRI and spectroscopy, known to demonstrate biomarkers for CD and NI. QoL will be assessed using the validated EQ-5D tool.

The Inclusion criteria; patients who survive their burns injury (greater than 15% total body surface area) and require mechanical ventilation. Primary exclusion criteria; admission with toxic epidermal necrolysis syndrome, and evidence of head trauma.

Description:

This is a novel, proof of principle, prospective, cohort design, observational clinical study to assess for functional brain reorganisation, structural changes and long-term cognitive dysfunction following major burns injury and intensive care admission. The hypothesis is that following a major burns injury and intensive care admission patients will have neurocognitive dysfunction and demonstrable functional alterations seen on functional MRI due to neuroinflammation as a result of the primary injury and subsequent inflammatory insults.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 32
• Est. completion date: October 30, 2017
• Est. primary completion date: April 30, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Survival following admission to Chelsea and Westminster Burns Intensive Care Unit between 2004-2013 with a burn injury > 15% total body surface area, requiring intubation and ventilation

Exclusion Criteria:

• Patients under 16.

• Patients with toxic epidermal necrolysis syndrome or evidence of head trauma.

• Patients with evidence of risk to psychological safety from inclusion in study: any patient currently held under section of the Mental Health Act, any patient receiving formal psychiatric treatment (including involvement in a Personality Disorder Unit, being under voluntary section, current re-occurrence of chronic self harm), any patient currently detained at her Majesty's pleasure, any current substance abuse, or at the discretion of professional opinion following historical assessment of notes. - Patients with contraindications to MRI (patients with non-compatible pacemakers, patients with metallic foreign bodies e.g. metal sliver in their eye, patients with non-compatible surgical metal work, patients with severe claustrophobia).

• Patient refusal or inability to give full informed consent.

• Patients unable to understand plain verbal or written English.

Related Conditions & MeSH terms

• Major Injury

Intervention

Behavioral:
• Face-to-face neurocognitive tests
Assessment of attention, processing speed, working memory and executive function
• Psychological screening
Screening for the symptoms of depression, anxiety and post-traumatic stress disorder

Other:
• fMRI
Brain volume, chemical markers, functional outcome

Behavioral:
• Quality of Life Self-Assessment data
EQ-5D will be converted into a utility score using standard EQ-5D UK tariffs

Locations

Country	Name	City	State
United Kingdom	The Burn Intensive Care Unit (BICU), Chelsea and Westminster Hospital	London

Sponsors (3)

Lead Sponsor	Collaborator
Chelsea and Westminster NHS Foundation Trust	Imperial College Healthcare NHS Trust, University of Westminster

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Long-term quality of Life	EQ-5D	5 years
Primary	Neurocognitive function	Specifically to investigate cognitive tasks using a battery of computerised tests.	5 years
Secondary	Neuroinflammatory changes analysis.	Functional MRI scan	5 years